A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)
Clinical trial NCT02641067 · COMPLETED
Trial details
- NCT number
- NCT02641067
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-26
- Primary completion
- 2016-05-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.